Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 305 | 528 | 278 | 384 | 313 |
| Cost of Goods | 19 | 75 | 31 | 56 | 37 |
| Gross Profit | 286 | 453 | 247 | 328 | 276 |
| Operating Expenses | 1,306 | 1,322 | 1,889 | 1,452 | 1,046 |
| Operating Income | -991 | -795 | -1,611 | -1,067 | -733 |
| Interest Expense | 0 | 7 | 7 | 7 | 8 |
| Other Income | 3 | -30 | 3 | 3 | 35 |
| Pre-tax Income | -988 | -832 | -1,615 | -1,071 | -706 |
| Net Income Continuous | -988 | -832 | -1,615 | -1,071 | -706 |
| Net Income | $-988 | $-832 | $-1,615 | $-1,071 | $-706 |
| EPS Basic Total Ops | -1.00 | -2.00 | -2.00 | -2.00 | -1.00 |
| EPS Basic Continuous Ops | -1.42 | -1.29 | -2.41 | -1.76 | -1.20 |
| EPS Diluted Total Ops | -1.00 | -2.00 | -2.00 | -2.00 | -1.00 |
| EPS Diluted Continuous Ops | -1.42 | -1.29 | -2.41 | -1.76 | -1.20 |
| EBITDA(a) | $-998 | $-780 | $-797 | $-1,020 | $-692 |